Fast Facts

Company name: Douglas Pharmaceuticals Limited
Company address: Central Park Drive, Henderson, Auckland
Date established: 1967
Managing Director: Sir Graeme Douglas MNZM FPS
Number of employees: 450
Capital: NZ$80m
Annual sales: NZ$143m

Product expertise:

  • High potency/containment manufacturing of softgel capsules, tablets, hard gelatin capsules, semisolids (e.g. retinoids, anticancer, immunosuppressants, steroids, Vitamin D analogues)
  • Microencapsulated API (Active Pharmaceutical Ingredient) products (e.g. retinoids)
  • Novel formulations
  • New strengths for existing products

Key products:

  • Anastrozole tablets (1 mg)
  • Azathioprine tablets (50 mg)
  • Bicalutamide tablets (50 mg)
  • Clozapine tablets (25 mg, 50 mg, 100 mg, 200 mg)
  • Clozapine suspension (50 mg/ml)
  • Cyproterone acetate tablets (50 mg, 100 mg)
  • Ethinylestradiol/cyproterone acetate tablets (35 mcg/2 mg)
  • Exemestane tablets (25 mg)
  • Isotretinoin softgel capsules (5 mg, 10 mg, 20 mg, 30 mg, 40 mg)
  • Letrozole tablets (2.5 mg)
  • Quetiapine tablets (25 mg, 100 mg, 200 mg, 300 mg)
  • Risperidone tablets (0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg)
  • Rivastigmine tartrate capsules (1.5 mg, 3 mg, 4.5 mg, 6 mg)

History snapshot

  • Founded in 1967, Douglas Pharmaceuticals was initially a marketer and distributor of ethical and over-the-counter (OTC) medicines in New Zealand. In the 1980s the company began manufacturing generic pharmaceuticals for the local market.
  • In the 1990s, as a consequence of New Zealand health sector reforms, Douglas increased its focus on export activities. This move resulted in the restructuring of core operations into two distinct business activities: domestic in-licensing and agency operations, to supply the New Zealand retail pharmacy sector own and in-licensed generics, OTC’s and nutraceutical/dietary supplements; and export out-licensing operations, to supply generic medicines and dietary supplements to global markets.
  • Douglas Pharmaceuticals’ domestic operation has grown to around $57 million annually and today employs one of the largest field sales teams in New Zealand. The sales team services retail pharmacy, health stores, hospitals, doctors and specialists.
  • Our export turnover has grown exponentially to more than $85 million. Currently we are supplying close to 30 generic products to more than 60 customers in 35 countries around the world.